These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29468766)

  • 1. Harms, benefits and the policing of cryptomarkets: a response to commentaries.
    Aldridge J; Stevens A; Barratt MJ
    Addiction; 2018 May; 113(5):802-804. PubMed ID: 29468766
    [No Abstract]   [Full Text] [Related]  

  • 2. Will growth in cryptomarket drug buying increase the harms of illicit drugs?
    Aldridge J; Stevens A; Barratt MJ
    Addiction; 2018 May; 113(5):789-796. PubMed ID: 28766792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The harm reduction impact of cryptomarkets: inequality and opportunity.
    Sumnall HR
    Addiction; 2018 May; 113(5):801-802. PubMed ID: 29152809
    [No Abstract]   [Full Text] [Related]  

  • 4. Looking to the future-more concern than optimism that cryptomarkets will reduce drug-related harms.
    Mounteney J; Cunningham A; Groshkova T; Sedefov R; Griffiths P
    Addiction; 2018 May; 113(5):799-800. PubMed ID: 29152807
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
    Tzanetakis M
    Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focus on cryptomarkets and online reviews too narrow to debate harms of drugs bought online.
    van der Gouwe D; Rigter S; Brunt TM
    Addiction; 2018 May; 113(5):798-799. PubMed ID: 29152812
    [No Abstract]   [Full Text] [Related]  

  • 7. 'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.
    Barratt MJ; Lenton S; Maddox A; Allen M
    Int J Drug Policy; 2016 Sep; 35():50-7. PubMed ID: 27157539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
    Aldridge J; Décary-Hétu D
    Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptomarkets, systemic violence and the 'gentrification hypothesis'.
    Martin J
    Addiction; 2018 May; 113(5):797-798. PubMed ID: 29044783
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Nice people doing shady things': Drugs and the morality of exchange in the darknet cryptomarkets.
    Masson K; Bancroft A
    Int J Drug Policy; 2018 Aug; 58():78-84. PubMed ID: 29870962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
    Aldridge J; Askew R
    Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
    Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
    Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge.
    Bancroft A; Scott Reid P
    Int J Drug Policy; 2016 Sep; 35():42-9. PubMed ID: 26777135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals.
    Hughes CE; Moxham-Hall V; Ritter A; Weatherburn D; MacCoun R
    Int J Drug Policy; 2017 Mar; 41():91-100. PubMed ID: 28131615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
    Broséus J; Morelato M; Tahtouh M; Roux C
    Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data.
    Moeller K; Munksgaard R; Demant J
    Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.
    Van Hout MC; Hearne E
    Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.
    Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C
    Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safer scoring? Cryptomarkets, social supply and drug market violence.
    Barratt MJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.